verapamil has been researched along with raclopride in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Asselin, MC; Boellaard, R; Froklage, FE; Huisman, MC; Lammertsma, AA; Mansor, SM; Schuit, RC; van Assema, DM; van Berckel, BN; van Velden, FH; Wang, S | 1 |
3 other study(ies) available for verapamil and raclopride
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of HRRT and HR+ scanners for quantitative (R)-[11C]verapamil, [11C]raclopride and [11C]flumazenil brain studies.
Topics: Brain; Carbon Radioisotopes; Case-Control Studies; Flumazenil; GABA Modulators; Healthy Volunteers; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Positron-Emission Tomography; Raclopride; Radioisotopes; Reference Values; Reproducibility of Results; Tissue Distribution; Tomography Scanners, X-Ray Computed; Tomography, X-Ray Computed; Vasodilator Agents; Verapamil | 2015 |